sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Middle East and Africa Virus-like Particles Market...

中东和非洲病毒样颗粒市场预测至 2028 年 - COVID-19 影响和按产品类型（肝炎、癌症/HPV 和戈谢病）、来源（酵母、昆虫细胞、植物等）和应用进行的区域分析（疫苗和治疗）

TIPRE00026830 | Pages: 117 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

市场介绍

阿拉伯联合酋长国（UAE）、沙特阿拉伯和南非中东及中东主要国家非洲地区。 2021年，沙特阿拉伯是该地区最大的病毒样颗粒市场。非洲沙特阿拉伯预计在预测期内将以更高的复合年增长率增长；这种增长归因于各种疾病患病率的上升以及政府在资金和医疗保健相关政策方面的举措不断增加。

经济的不确定性和持续的冲突正在使该地区的状况恶化。例如，叙利亚、利比亚、也门等国家正遭受暴力冲突，无法实施任何公共卫生措施。由于美国的制裁，伊朗经济陷入严重衰退。此外，金融状况收紧也减少了该地区的经济活动。该地区许多国家都面临着新冠疫苗短缺的问题。该地区各个发展中国家的新冠疫苗供应滞后。因此，全球疫苗制造商有潜力探索中东非洲未开发的地区。例如，根据布鲁金斯学会2021年8月公布的数据，中东非中低收入国家的疫苗接种率估计为约旦25%、摩洛哥27%，中东非地区尚无国家接种疫苗。能够为超过 15% 的人口提供一剂疫苗。因此，为该地区的 VLP 相关市场提供了潜在的市场，并对该地区的 VLP 市场产生了积极影响。

市场概况和动态

u>

中东和非洲的病毒样颗粒市场非洲预计将从2021年的1.5283亿美元增长到2028年的2.4912亿美元；预计 2021 年至 2028 年复合年增长率为 7.2%。医疗保健市场的各个参与者和研究机构都积极参与产品创新和开发。使用病毒样颗粒是生物制药行业中使用的一种新兴方法。由于病毒样颗粒缺乏病毒成分，因此它们比实际的病毒成分更容易处理。 VLP 可用于辅助药物输送、成像、免疫治疗和治疗诊断。例如，根据 NCBI 2020 年 6 月发表的一项研究，VLP 可以纳米颗粒的形式用于光热疗法、PET 和 CT 成像、MRI 造影剂载体、光学成像、炎症和自身免疫性疾病疫苗等应用，癌症免疫疗法和小分子药物输送（在癌症治疗中）。因此，VLP 的此类潜在应用预计将在预测期内为市场参与者提供增长机会。

关键细分市场

从产品类型来看，中东和中东地区肝炎细分市场占比最大。 2021年非洲病毒样颗粒市场。从来源来看，酵母细分市场占中东和非洲地区最大份额。 2021年非洲病毒样颗粒市场。从应用来看，2021年病毒样颗粒市场中疫苗细分市场占有较大份额。

主要来源和上市公司

准备本中部地区病毒样颗粒市场报告时提到的一些主要一手和二手来源东&非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司是默克公司（Merck & Company）。有限公司；葛兰素史克公司；辉瑞公司；赛诺菲；印度血清研究所列兵。有限公司；巴拉特生物技术公司； LG化学；和 VBI Vaccines Inc. 等。

购买报告的理由

  • 了解中东和中东地区非洲类病毒颗粒市场格局并确定最有可能保证强劲回报的细分市场
  • 了解中东不断变化的竞争格局，保持领先地位&非洲类病毒颗粒市场
  • 高效规划中东和非洲的并购和合作交易通过识别最有希望销售的细分市场，非洲病毒类颗粒市场
  • 通过对中东各个细分市场的市场表现进行敏锐和全面的分析，帮助做出明智的业务决策&非洲病毒样颗粒市场
  • 获取中东和非洲各细分市场2021-2028年的市场收入预测。非洲地区。

中东和非洲地区非洲类病毒颗粒市场细分

 

< span>中东和中东地区非洲病毒样颗粒市场 - 按产品类型

  • 肝炎
  • 癌症/HPV
  • 戈谢病

中东和中东地区非洲病毒样颗粒市场 - 按来源

  • 酵母
  • 昆虫细胞
  • 植物
  • 其他

< strong>中东和中东地区非洲病毒样颗粒市场 - 按应用

  • 疫苗
  • 治疗学

中东和中东地区非洲病毒样颗粒市场 - 按国家

  • 沙特阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区;   

中东和中东地区非洲病毒样颗粒市场 - 提及的公司

  • 默克公司                   ;                  &n公共服务提供商;      
  • 葛兰素史克公司
  • 辉瑞公司;                  &n公共服务提供商;                  &n公共服务提供商;               
  • 赛诺菲                             ;                     ;               
  • 印度血清研究所列兵。                       
  • 巴拉特生物科技            ;                  &n公共服务提供商;            
  • LG化学                                       ;                 
  • VBI 疫苗公司                    ;         

1.            Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Virus-like Particles Market – By Product Type

1.3.2        Middle East & Africa Virus-like Particles Market – By Source

1.3.3        Middle East & Africa Virus-like Particles Market – By Application

1.3.4        Middle East & Africa Virus-like Particles Market – By Country

2.           Middle East & Africa Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Middle East & Africa Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Higher Prevalence of Infectious Viral Diseases

5.1.2        Fostering Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Existence of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Increasing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Regular Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Middle East & Africa Virus-like Particles Market Analysis

6.1         Middle East & Africa Virus-like Particles Market Revenue Forecast and Analysis

7.           Middle East & Africa Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Middle East & Africa Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Middle East & Africa Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Middle East & Africa Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.1.5       UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.2.5       Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.3.5       South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Million)

10.1.1.4.5       Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Middle East & Africa Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Middle East & Africa Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      VBI Vaccines Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Middle East & Africa Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 3.             UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 9.             South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           Middle East & Africa Virus-like particles Market Segmentation

Figure 2.           Middle East & Africa Virus-like particles Market Segmentation, By Country

Figure 3.           Middle East & Africa Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Middle East & Africa Virus-like particles Market

Figure 5.           Saudi Arabia to Show Significant Growth during Forecast Period

Figure 6.           Middle East & Africa Virus-like Particles Market, Industry Landscape

Figure 7.           Middle East & Africa PEST Analysis

Figure 8.           Middle East & Africa Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Middle East & Africa Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Middle East & Africa Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Middle East & Africa Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Middle East & Africa Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Impact Of COVID-19 Pandemic in Middle East & African Countries

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  8. VBI Vaccines Inc.                                                       
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Middle East and Africa Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and S.. May 2022
Middle East and Africa Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, En.. May 2022
Middle East and Africa In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe M.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription